Literature DB >> 8649738

Osteosarcoma and its variants.

R A Vander Griend1.   

Abstract

Osteosarcoma is the most common primary malignant tumor of bone. The variability of this tumor and its histologic variants in presentation, location, and biologic behavior has an influence on the prognosis and determines treatment options. Despite improvements in both survival and function due to limb salvage techniques and adjuvant chemotherapy, osteosarcoma continues to be a major challenge for the medical and surgical oncologist.

Entities:  

Mesh:

Year:  1996        PMID: 8649738

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  18 in total

1.  The role of mechano-growth factor E peptide in the regulation of osteosarcoma.

Authors:  Jin Shang; Xin Fan; Huan Liu
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

Review 2.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

3.  The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma.

Authors:  Li Cheng; Xiaojie Wei; Keqi Zhao; Fenzan Wu; Wenjie Lu; Songlin Tong; Guanzhen Yu
Journal:  Tumour Biol       Date:  2016-09-20

4.  Posttraumatic reactive fibrous bone neoformation of the anterior skull base mimicking osteosarcoma.

Authors:  Jens Pfeiffer; Gian Kayser; Carsten C Boedeker; Gerd J Ridder
Journal:  Skull Base       Date:  2008-09

5.  Cellular and phenotypic characterization of canine osteosarcoma cell lines.

Authors:  Marie E Legare; Jamie Bush; Amanda K Ashley; Taka Kato; William H Hanneman
Journal:  J Cancer       Date:  2011-05-04       Impact factor: 4.207

6.  Non surgical treatment of sacral osteosarcoma.

Authors:  S A Aledavood; A Amirabadi; B Memar
Journal:  Iran J Cancer Prev       Date:  2012

7.  Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy.

Authors:  Parastou Foroutan; Jenny M Kreahling; David L Morse; Olya Grove; Mark C Lloyd; Damon Reed; Meera Raghavan; Soner Altiok; Gary V Martinez; Robert J Gillies
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  A review of targeted therapies evaluated by the pediatric preclinical testing program for osteosarcoma.

Authors:  Valerie B Sampson; Richard Gorlick; Davida Kamara; E Anders Kolb
Journal:  Front Oncol       Date:  2013-05-31       Impact factor: 6.244

Review 9.  MicroRNAs and Potential Targets in Osteosarcoma: Review.

Authors:  Valerie B Sampson; Soonmoon Yoo; Asmita Kumar; Nancy S Vetter; E Anders Kolb
Journal:  Front Pediatr       Date:  2015-08-24       Impact factor: 3.418

10.  Regional anesthesia for an upper extremity amputation for palliative care in a patient with end-stage osteosarcoma complicated by a large anterior mediastinal mass.

Authors:  Mumin Hakim; Candice Burrier; Tarun Bhalla; Vidya T Raman; David P Martin; Olamide Dairo; Joel L Mayerson; Joseph D Tobias
Journal:  J Pain Res       Date:  2015-09-24       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.